261 related articles for article (PubMed ID: 20632831)
1. Systemic mastocytosis associated with acute myeloid leukaemia.
Fong C; Tong M
Pathology; 2010; 42(5):485-7. PubMed ID: 20632831
[No Abstract] [Full Text] [Related]
2. Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
Marbello L; Anghilieri M; Nosari A; Minola E; Cairoli R; Ricci F; Morra E
Haematologica; 2004 Sep; 89(9):ECR35. PubMed ID: 15377487
[TBL] [Abstract][Full Text] [Related]
3. Systemic mastocytosis in a child with t(8;21) acute myeloid leukemia.
Mahadeo KM; Wolgast L; McMahon C; Cole PD
Pediatr Blood Cancer; 2011 Oct; 57(4):684-7. PubMed ID: 21671435
[TBL] [Abstract][Full Text] [Related]
4. Systemic mastocytosis associated with acute myeloid leukaemia.
Kim MJ; Kim MK; Kim YK; Gu MJ
Pathology; 2017 Oct; 49(6):652-654. PubMed ID: 28826833
[No Abstract] [Full Text] [Related]
5. Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience.
Hennessy B; Giles F; Cortes J; O'brien S; Ferrajoli A; Ossa G; Garcia-Manero G; Faderl S; Kantarjian H; Verstovsek S
Am J Hematol; 2004 Nov; 77(3):209-14. PubMed ID: 15495258
[TBL] [Abstract][Full Text] [Related]
6. Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis.
Escribano L; Garca-Montero A; Núñez-López R; López-Jiménez J; Almeida J; Prados A; Orfao A
J Allergy Clin Immunol; 2004 Jul; 114(1):28-33. PubMed ID: 15241340
[TBL] [Abstract][Full Text] [Related]
7. [Neoplastic mastocytosis evolving from a poor prognosis acute myeloid leukemia].
Chen-Liang TH; Jerez A; Florensa L; Ortuño FJ
Med Clin (Barc); 2015 Jun; 144(12):571-2. PubMed ID: 25249393
[No Abstract] [Full Text] [Related]
8. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge.
Arredondo AR; Gotlib J; Shier L; Medeiros B; Wong K; Cherry A; Corless C; Arber DA; Valent P; George TI
Am J Hematol; 2010 Aug; 85(8):600-6. PubMed ID: 20658589
[No Abstract] [Full Text] [Related]
9. Intrahepatic cholestasis due to systemic mastocytosis: a case report and review of literature.
Safyan EL; Veerabagu MP; Swerdlow SH; Lee RG; Rakela J
Am J Gastroenterol; 1997 Jul; 92(7):1197-200. PubMed ID: 9219799
[TBL] [Abstract][Full Text] [Related]
10. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone.
Pullarkat V; Bedell V; Kim Y; Bhatia R; Nakamura R; Forman S; Sun J; Senitzer D; Slovak ML
Leuk Res; 2007 Feb; 31(2):261-5. PubMed ID: 16876862
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.
Ustun C; Corless CL; Savage N; Fiskus W; Manaloor E; Heinrich MC; Lewis G; Ramalingam P; Kepten I; Jillella A; Bhalla K
Leuk Res; 2009 May; 33(5):735-41. PubMed ID: 18986703
[TBL] [Abstract][Full Text] [Related]
12. Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease.
Hauswirth AW; Födinger M; Fritz M; Müllauer L; Simonitsch-Klupp I; Streubel B; Chott A; Sperr WR; Jäger U; Valent P
Hum Pathol; 2008 Jun; 39(6):917-24. PubMed ID: 18448146
[TBL] [Abstract][Full Text] [Related]
13. Systemic mastocytosis with associated acute myeloid leukemia with t (8; 21) (q22; q22).
Gadage VS; Kadam Amare PS; Galani KS; Mittal N
Indian J Pathol Microbiol; 2012; 55(3):409-12. PubMed ID: 23032848
[TBL] [Abstract][Full Text] [Related]
14. Systemic mastocytosis associated with acute myeloid leukemia.
Nogueira FL; Martins NNN; Cardoso PSR; Murao M; de Melo FHC; Glória ABF; Fagundes EM
Ann Hematol; 2020 Jan; 99(1):195-196. PubMed ID: 31768674
[No Abstract] [Full Text] [Related]
15. Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene.
Mayeur-Rousse C; Sorel N; Voldoire M; Canioni D; Brizard F; Randriamalala E; Turhan AG; Chomel JC
Leuk Res; 2012 Mar; 36(3):377-81. PubMed ID: 22030335
[No Abstract] [Full Text] [Related]
16. Idarubicin in combination with etoposide and cytarabine in adult acute non-lymphoblastic leukaemia (ANLL).
Carella AM; Pungolino E; Piatti G; Giordano D; Cerri R; Risso M; Nati S
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():50-1. PubMed ID: 2713562
[No Abstract] [Full Text] [Related]
17. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
[TBL] [Abstract][Full Text] [Related]
18. Bullous leukaemia cutis.
Kikuchi N; Yamamoto T
Eur J Dermatol; 2012; 22(1):148-9. PubMed ID: 22237386
[No Abstract] [Full Text] [Related]
19. Clearance of bone marrow mast cells after hypomethylating agent and venetoclax for systemic mastocytosis associated with myeloid neoplasia.
Pourhassan H; Kim Y; Pullarkat V
Eur J Haematol; 2023 Feb; 110(2):213-216. PubMed ID: 36335580
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukaemia with abnormal eosinophil precursors without inversion 16.
Rashidi A; Roullet MR
Br J Haematol; 2012 Sep; 158(5):561. PubMed ID: 22758220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
